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ABSTRACT
Background: Oculomotor nerve schwannoma (ONS) is an extremely rare intracranial benign tumor. Till date, there 
is no standard treatment of oculomotor schwannoma. Here, we present an illustrative case report of ONS, perform a 
systematic review of literature on surgically and radiosurgically treated cases and morbidity related to both treatment 
modalities.
Methods: We performed a systematic review of literature for cases with ONS treated with surgery or radiosurgery 
using PubMed/Ovid Medline.
Results: Till date, there are 60 reported cases of ONS (45 treated surgically and seven radiosurgically) with the 
dominance of female gender (53%) and mean age of 35.2  years (Range 1–66). In 8% of the cases, there was no 
involvement of cranial nerve (CN) III and 92% of the cases CN III alone or together with CN II, IV, V, and VI. In 
67% of the cases a complete resection and 33% a partial resection performed. In 73% of the cases, postoperative third 
nerve palsy was documented, 22% improved after surgery and in around 5% of cases, the outcome was not described. 
In the radiosurgically treated cases of nonvestibular schwannoma including ONS, the progression-free interval of 
approximately 2 years was above 90%.
Conclusion: Due to the high rate of postoperative complete oculomotor nerve palsy, a subtotal resection avoiding 
the nerve injury seems to be a feasible option. Radiosurgery is another option to treat small size schwannoma. 
A  combined treatment with microsurgery followed by radiosurgery may allow effective treatment for large size 
oculomotor schwannoma.
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Intracranial schwannoma accounts for around 7% of all intracranial tumors.[9] Most of the intracranial 
schwannoma, however, arise from the sensory division of cranial nerves (CNs) including vestibular nerve 
followed by the trigeminal nerve.[11] Being purely motor nerve, oculomotor nerve schwannoma (ONS) 
is an extremely rare tumor unless associated with Recklinghausen’s disease. e transition zone of the 
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third nerve from central to the periphery is 0.6 mm; hence, these 
tumors can occur over multiple anatomical locations including 
interpeduncular cistern, parasellar, cavernous sinus (CS) region, 
orbital apex, and intraorbital. In large tumors radiologically and 
intraoperatively it is difficult to detect from which nerve the tumor 
arises; however, a selective postoperative deficit of the harboring 
nerve can identify its source.
Till date, around five dozens of cases of ONS have been reported 
in literature. Most of the cases reported in the literature have been 
treated surgically with a very high rate of complete third nerve 
palsy that adds significant morbidity. Although radiosurgery 
could be an alternative, only a few successfully treated cases with 
radiosurgery have been reported in literature.[3,6,7,10] Till date, there 
is no standard treatment of oculomotor schwannoma.
Hence, we review surgically and radiosurgically treated cases and 
morbidity reported in these cases and discusses alternative options 
to treat these tumors. Furthermore, we present an illustrative case 
of ONS treated surgically in our department.
MATERIALS AND METHODS
Case report
A 64-years-old male presented with a history of exophthalmos 
and blurry vision on the left side for 3 years. On examination, 
the patient was alert and oriented to all qualities. Visual field 
was intact and pupil size was normal and reactive to light. e 
patient showed a slight restriction of ocular movements as a 
sign of partial oculomotor palsy. Magnetic resonance imaging 
(MRI) scan showed a 5.6 cm contrast enhancing lesion on the 
left orbital apex with extension in the middle fossa [Figure 1a 
to Figure 1f]. e whole tumor was located extradural. In 
the medical history, patient was operated on left orbital mass 
through a left-sided lateral orbitotomy 36 years ago. Histological 
and operative finding at that time suggested a “Neurilemmoma” 
of V1. Ophthalmic nerve was cut on both sides of the tumor to 
remove the tumor completely. Pat. developed hypestesia in V1 
after the operation.
LITERATURE REVIEW
Review of literature for cases of ONS that were treated with 
surgery was performed using PubMed, Ovid Medline, and Scopus 
database. We used the PRISMA checklist as a guide to achieve 
accepted standards for reporting system reviews. e first author 
performed all steps and discussed with senior author.
We used keywords “oculomotor nerve” in combination with 
“schwannoma” and “surgery” or “radiosurgery.” A total of 141 
related articles were yielded. Articles in nonEnglish language 
were excluded. e articles without any kind of treatment were 
also excluded. Finally, 60 articles were considered suitable 
for review.
RESULTS
Surgical resection and operative findings
After exclusion of irrelevant articles according to above-mentioned 
exclusion criteria, 60 articles were considered to be included in 
our analysis. We analyzed age, size, location of schwannoma, 
involvement of CNs, extent of surgical resection, and the third 
nerve palsy after surgery. e analysis of data from included articles 
showed that oculomotor schwannoma is slightly more in female 
gender (53%) and mean age of 35.2 years (standard deviation = 19.5, 
range 1–66). In 8% of the cases there was no involvement of CN III 
and 92% of the cases there was either CN III alone or together with 
CN II, IV, V, and VI affected [Table  1]. 45 of the reported cases 
were treated with surgery and there are only 4 reports with 7 cases 
treated with radiosurgery. In 67% of the cases a complete resection 
and in 33% a partial resection performed [Table  2]. In most of 
the cases, the tumor was located in the interpeduncular cistern, 
CS, or cistern-cavernous region [Table 2]. Only a few cases with 
intraorbital or middle fossa location have been reported [Table 2]. 
Location and size of the tumor are extremely important to plan 
the extent of resection. Due to the large size of the tumor with a 
diameter of 56 mm and mass effect we preferred surgical resection 
that is in line with literature. Surgery was performed through 
a lateral supraorbital approach using OPMI PENTERO 900 
microscope (Carl-Zeiz, Germany). We used this approach as we are 
more familiar to the approach for such tumor locations. Dura was 
opened in a curved fashion to inspect the presence of any tumor. 
In line with the radiological findings, the tumor was located in 
temporal fossa in extradural space compressing the temporal lobe 
laterally, optic nerve medially and oculomotor nerve downwards 
and the tumor extended toward the superior orbital fissure along 
the third nerve. In the present case, a subtotal resection with > 90% 
of tumor removal was performed. e thin layer of the tumor along 
the course of oculomotor nerve was left intact to avoid the axonal 
injury to the oculomotor nerve. Dura was closed in a watertight 
fashion.
Figure 1: Preoperative (a-c) and postoperative (d-f) magnetic resonance 
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(Contd...)
Author Year Age Sex Label (m/f) Involvement of CN Symptoms
Kovacs 1927 55 m 1 III and V Incidental
Nagamune et al. 1974 46 f 2 III Diplopia
Kan et al. 1976 36 m 1 III Diplopia
Huber et al. 1978 55 m 1 III, IV Reduced vision
Huber et al. 1978 52 m 1 III Diplopia
Huber et al. 1978 40 f 2 III Reduced vision
Schubiger 1980 19 f 2 III Headache
Broggi Franzini 1981 45 m 1 III Hemiparesis
Hiscott and Symon 1982 58 f 2 III Hemiparesis, drowsiness
Leunda et al. 1982 11 m 1 III headache, Hemiparesis
Kansu et al. 1982 15 m 1 III headache
Okamoto et al. 1985 52 f 2 III, V, VI Diplopia
Ishige et al. 1985 64 f 2 IV, V, VI Periorbital pain
Satoh et al. 1985 46 f 2 III Headache
Nogami et al. 1986 40 f 2 none headache
Bataille 1987 54 f 2 III Diplopia, headache
Katsumata et al. 1990 47 m 1 III, V Diplopia, Ptosis
Lunardi et al. 1990 60 f 2 III, IV Headache
Mehta et al. 1990 19 f 2 none Gait disturbance
Takano et al. 1990 65 m 1 III Ptosis, diplopia
Kurokawa et al. 1992 55 m 1 none Diplopia
Barat et al. 1992 27 f 2 None Exophthalmos, vision loss,
Kadota et al. 1993 41 m 1 III Diplopia, Ptosis
Schultheiss et al. 1993 65 m 1 III, V Incidental
Niazi and Boggan 1994 13 f 2 III, V Hemiparesis, Diplopia
Kachara et al. 1998 55 m 1 III Headache
Kachara et al. 1998 61 m 1 III reduced vision
Asaoka et al. 1999 64 f 2 II, III Headache
Mariniello et al. 1999 8 f 2 III Diplopia
Kawasaki et al. 1999 23 f 2 III headache
Lingavi et al. 2000 23 m 1 III, IV, V headache
Katoh et al. 2000 66 f 2 II, III Incidental
Sarma et al. 2002 36 f 2 III Diplopia
Hatakeyama et al. 2003 33 m 1 III Diplopia
Netuka and Benes 2003 12 f 2 III Headache
Murakami et al. 2005 11 f 2 III headache, diplopia, ptosis
Bisdorf and Wildanger 2006 14 f 2 III headache
Kozic et al. 2006 9 m 1 III Diplopia, ptosis
Sener et al. 2006 1 m 1 III Ptosis
Ohata et al. 2006 63 f 2 II/III Diplopia, Ptosis
Tanriover et al. 2007 34 f 2 II/III Headache, Ptosis, anisocoria, exotropia
Chewning et al. 2008 3 f 2 III headache, ptosis
Shamim et al. 2008 11 f 2 III Diplopia, blindness
Prabhu and Bruner 2010 38 f 2 III Headache, Diplopia, Ptosis, Dizziness
Goel and Shah 2010 32 m 1 III Headache, Diplopia, Ptosis
Goel and Shah 2010 16 m 1 III Headache, Ptosis
Safavi-Abbasi et al. 2010 61 F 2 III Diplopia
Saetia et al. 2011 41 m 1 II Visual loss
Furtado et al. 2012 21 m 1 III Diplopia
Furtado et al. 2012 25 m 1 III Diplopia
Nagashima et al. 2012 5 m 1 III Ptosis, exophthalmos
Iijima et al. 2013 37 f 2 III Hydrocephalus, anisocoria, semicoma
Yang et al. 2013 3 m 1 None Irritability, Convulsion
Cho et al. 2014 41 f 2 II Visual disturbance
Kauser et al. 2014 32 m 1 III Ptosis
Kumar et al. 2014 29 m 1 II, III Diplopia, blurry vision
Table 1: Review of literature on all cases of oculomotor nerve schwannoma.
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Author Year Age Sex Label (m/f) Involvement of CN Symptoms
Senapati et al. 2014 24 f 2 III Diplopia, ptosis
Mariniello et al. 2017 16 f 2 III Proptosis
Mariniello et al. 2017 51 f 2 III Proptosis
Mariniello et al. 2017 38 m 1 III Proptosis
Table 1: (Continued)
Table 2: Review of literature on surgically treated cases of oculomotor nerve schwannoma.
Author Year Age Sex Symptoms Involvement Max. 
Division
Location Resection  
(Total/pa)
III-Nerve-p Post-operative
Schubiger 1980 19 f Headache III and V 30 CS Total No No
Broggi Franzini 1981 45 m Hemiparesis III 30 CI Total No ND
Hiscott and Symon 1982 58 f Hemiparesis, drowsiness III 40 CI Subtotal Yes Yes
Leunda et al. 1982 11 m Headache, Hemiparesis III, IV 55 CI Total Yes Yes
Kansu et al. 1982 15 m Headache III 4 CS Total Yes ND
Okamoto et al. 1985 52 f Diplopia III 40 CS- O Subtotal Yes Yes
Nogami et al. 1986 40 f Headache III 15 CI Total Yes Yes
Katsumata et al. 1990 47 m Diplopia, ptosis III 15 CI Total Yes Yes
Lunardi et al. 1990 60 f Headache III 35 CI Total Yes Yes
Mehta et al. 1990 19 f Gait disturbance III 50 CS Subtotal Yes Yes
Takano et al. 1990 65 m Ptosis, diplopia III 25 CS-MF Subtotal Yes Yes
Kurokawa et al. 1992 55 m Diplopia III, V, VI 20 CS Total Yes Yes
Barat et al. 1992 27 f Exophthalmos, vision loss IV, V, VI 40 CS-O Total Yes Yes
Kadota et al. 1993 41 m Diplopia, Ptosis III 20 CS Total Yes Yes
Schultheiss et al. 1993 65 m Incidental none 8 CS Total No No
Niazi and Boggan 1994 13 f Hemiparesis, Diplopia III 30 CS Total Yes Yes
Kachara et al. 1998 55 m Headache III, V 20 CS Total Yes Yes
Kachara et al. 1998 61 m Reduced vision III, IV 40 CS Total Yes Yes
Asaoka et al. 1999 64 f Headache none 15 CI Subtotal No No
Mariniello et al. 1999 8 f Diplopia III 10 CS Total Yes Yes
Lingavi et al. 2000 23 m Headache none 5 CI Total No No
Katoh et al. 2000 66 f No None 15 CI-CS Subtotal No Yes
Sarma et al. 2002 36 f Diplopia III 10 CS Total Yes Yes
Hatakeyama et al. 2003 33 m Diplopia III, V 40 CI-CS Total YES NO
Netuka and Benes 2003 12 f Headache V 28 CI-CS Total NO NO
Ohata et al. 2006 63 f Diplopia, Ptosis III 30 CS-O Subtotal Yes Yes
Tanriover et al. 2007 34 f Headache, Ptosis, anisocoria, ex III 20 CS-O Subtotal YES NO
Shamim et al. 2008 11 f Diplopia, blindness II, III 25 O Total Yes Yes
Prabhu and Bruner 2010 38 f Headache, Diplopia, Ptosis, Dizzi III 35 CI Total Yes Yes
Goel and Shah 2010 32 m Headache, Diplopia, Ptosis III 40 CI-CS Subtotal Yes No
Goel and Shah 2010 16 m Headache, Ptosis III, IV, V 30 CI-CS Total Yes Yes
Saetia et al. 2011 41 m Visual loss II, III 45 CS Total Yes Yes
Furtado et al. 2012 21 m Diplopia III 15 CI-O Subtotal Yes Yes
Furtado et al. 2012 25 m Diplopia III 50 CS Subtotal Yes Yes
Nagashima et al. 2012 5 m Ptosis, exophthalmos III 35 O Total Yes Yes
Iijima et al. 2013 37 f Hydrocephalus, anisocoria, sem III 50 CI-CS Subtotal Yes Yes
Yang et al. 2013 3 m Irritability, Convulsion III 13 CI Total Yes Yes
Cho et al. 2014 41 f Visual disturbance II 24 CS-O Subtotal No Yes
Kauser et al. 2014 32 m Ptosis III 43 CS-IO Total Yes Yes
Kumar et al. 2014 29 m Diplopia, blurry vision II/III 69 CS Subtotal Yes Yes
Senapati et al. 2014 24 f Diplopia, ptosis II/III 62 CS Total Yes Yes
Mariniello et al. 2017 16 f Proptosis III 17 CS-CI Total Yes Yes
Mariniello et al. 2017 51 f Proptosis III 20 CS Total Yes No
Mariniello et al. 2017 38 m proptosis III 32 CS Total Yes No
Muhammad et al. 2018 64 m Exophthalmos, blurry vision III 56 MF-O Subtotal Yes Yes
CS: Cavernous sinus, CI: Cisternal, MF: Midel fossa, O: Orbital, CS-O: Cavernous sinus plus intraorbital, CI-CS: Cisterno-cavernous, CS-MF: CS plus midle fossa, 
MF-O: Midle fossa plus orbital, CO: Cisterno-orbital
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Tumor type Clinical outcome
Kim et al. 
2008






1. Mean progression-free interval 23 months
2. No improvement of ONP in 2 cases
Nishioka 
et al. 2008






1. 47% of cases improved, 53% remained unchanged
2. No side effects or worsening of symptoms
Kimmball 
et al. 2011






1. Local tumor control was 97% at 1 year, 91% at 4.5 years, and 83% at 5 years
2. CN deficits 9%
Elsharkawy 
et al. 2012






1. e 2-year actuarial progression-free survival was 91%
ONS: Oculomotor nerve schwannoma, RS: Radiosurgery, CN: Cranial nerve, ONP: Oculomotor nerve palsy
Postoperative outcome
Postoperatively patient developed complete oculomotor nerve palsy 
with ptosis and dilated the fixed pupil. On discharge from the hospital 
a slight recovery with almost normalized pupil size was observed. 
In the short-term follow-up of 3 months the partial recovery with 
normalized and to the light reactive pupil and a partial recovery of 
ptosis (could open the eye around 1 cm) was documented.
DISCUSSION
ONSs are slow growing rare tumors. ere is no standard treatment 
strategy for such a tumor. Hence, we reviewed the existing 
literature for treatment modality and reported the outcome. ONS 
is located at the course of nerve either in cisternal (CI) space, 
cisterno-cavernous region, orbital apex and rarely in the orbita 
[Table 2]. e clinical symptoms depend on the size and location, 
but a certain degree of third nerve palsy is almost always present.[5] 
Most common symptoms include ptosis and diplopia [Table  1]. 
Tumor growth toward the optic nerve can cause papilledema 
and vision loss and in rare cases hydrocephalus.[4] in section 
MRI (1–2  mm) with gadolinium enhancement is the choice of 
radiologic diagnostic for visualization and evaluation of CN 
pathologies. In larger sized tumors, it is difficult to exactly define 
the origin of the tumor. In addition to specific CN palsy, the tumor 
growth along the course of the particular nerve is another clue 
for the diagnosis. In the present case, tumor was grown from the 
orbital apex along the third nerve occupying the space between 
optic and oculomotor nerve and further growth in the middle 
fossa toward the temporal pole [Figure 1]. Pre- and postoperative 
clinical outcome, radiological and intraoperative features suggest 
that tumor arose from the third nerve. In most of the cases in 
literature, tumor location is the CI or CS region [Table 1].
Due to benign nature of the tumor, a maximum resection of the 
tumor is the surgical goal. However, the oculomotor nerve is very 
fragile and can be easily injured in an attempt to complete tumor 
removal. Most of the surgically treated cases showed postoperative 
complete third nerve palsy [Table 1]. Review of current literature 
showed that 73% of the cases developed postoperative third nerve 
palsy and 22% improved after surgery. In around 5% of cases, the 
outcome was not described [Table 2]. Oculomotor nerve seems to 
be very sensitive to injury as even a partial resection in most of the 
cases led to postoperative ON palsy. A radical tumor resection in 
the CS with cutting the third nerve and grafting the sural nerve led 
to a partial recovery of oculomotor function.[8] e chance of nerve 
injury increases if the tumor is located more anteriorly toward the 
superior orbital fissure than in the CI region.[12] All case reports 
except one[2] where the tumor located in the orbital apex showed 
complete third nerve palsy after the operation. e reason might 
be that Cho and Han performed the subtotal resection to avoid the 
nerve injury. Hence, the extent of tumor resection may be influenced 
by its location. Due to the morbidity associated with third nerve 
palsy the alternative strategy might be the subtotal resection.[1,12] 
Wait and see policy might be the right choice only in patients with 
the asymptomatic tumor.[5] Gamma knife radiosurgery has been 
reported to be the effective treatment modality for oculomotor, 
trochlear, and abducence nerve schwannomas without risk of CN 
palsy.[6] However, there is only a few case series of nonvestibular 
nerve schwannoma in literature treated with radiosurgery. In 
radiosurgically treated cases of nonvestibular schwannoma series 
including 7 cases of ONS report approximately <10% complications 
[Table 3]. ese small series of radiosurgery, however, include all 
nonvestibular schwannoma that does not completely reflect the 
ONS. e radiosurgical treatment results are, however, encouraging 
for small size tumors.[7,10] More data are needed to evaluate the 
superiority of radiosurgery over the microsurgery.
CONCLUSION
Due to the high rate of postoperative complete oculomotor nerve 
palsy, a subtotal resection avoiding the nerve injury seems to be 
a feasible option. Radiosurgery is another option to treat small 
size schwannoma. A  combined treatment with microsurgery 
followed by radiosurgery may allow effective treatment for large 
size oculomotor schwannoma.
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